Company research / EYPT

EyePoint, Inc. (EYPT)

CIK 0001314102 · Nasdaq · Laboratory Analytical Instruments

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends around Dec 31

For the year ended 2025-12-31, EyePoint, Inc. reported revenue of $31.37M. Revenue fell 27.5% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $2.79M.

Key ratios (year ended 2025-12-31)

-776.0%
Operating margin
-739.4%
Net margin
-75.8%
Return on year-end equity
-27.5%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-10-19

Headquarters locality: Watertown · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-30
2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312018-06-302017-06-30
Revenue$2.79M$31.37M$43.27M$46.02M$41.40M$36.94M$34.44M$20.36M$4.57Mn/a$7.54M
R&D Expense$262.72M$221.04M$132.93M$64.66M$49.64M$28.50M$17.42M$15.37M$18.50Mn/a$14.88M
Operating Income-$316.98M-$243.43M-$145.85M-$75.07M-$99.64M-$55.28M-$37.29M-$47.86M-$39.02Mn/a-$18.58M
Depreciation & Amortization$2.60M$2.31M$1.54M$464.0Kn/an/an/an/an/an/an/a
EBITDA-$314.38M-$241.12M-$144.31M-$74.60Mn/an/an/an/an/an/an/a
Net Income-$306.64M-$231.96M-$130.87M-$70.80M-$102.25M-$58.42M-$45.39M-$56.79M-$86.12Mn/a-$18.48M
EPS (Diluted)n/a-$3.17-$2.32-$1.82-$2.74-$2.03n/an/an/an/a-$0.52
Total Assets$228.19M$364.00M$418.46M$355.18M$180.36M$263.37M$91.72M$72.97M$78.17M$71.67M$18.68M
Total Liabilities$61.78M$57.88M$81.96M$88.86M$83.99M$78.99M$73.18M$64.64M$40.53M$59.98M$5.34M
Long-Term Debtn/an/an/an/a$30.00Mn/an/an/an/an/an/a
Shareholders' Equity$166.41M$306.11M$336.50M$266.32M$96.37M$184.38M$18.54M$8.33M$37.63M$11.69M$13.34M
Cash & Equivalents$110.46M$101.82M$99.70M$281.26M$95.63M$178.59M$44.91M$22.21M$45.26M$38.78M$16.90M
Operating Cash Flow-$267.30M-$240.11M-$126.23M$1.88M-$65.00M-$50.10M-$14.44M-$56.70Mn/a-$21.91M-$20.49M
Capital Expenditures$3.98M$3.28M$4.05M$3.48M$2.15M$156.0K$362.0K$213.0Kn/a$108.0K$147.0K
Free Cash Flow-$271.28M-$243.39M-$130.28M-$1.61M-$67.16M-$50.25M-$14.80M-$56.91Mn/a-$22.02M-$20.64M
Shares Outstanding84.98M82.83M68.27M49.04M34.08M33.91M18.14M10.94M95.37M74.51M39.36M
Weighted Average Diluted Sharesn/an/an/a38.90M37.32M28.76Mn/an/an/an/a35.34M
EPS (Basic)n/a-$3.17-$2.32-$1.82-$2.74-$2.03n/an/an/an/a-$0.52

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView